Cryomass Technologies Financials
| CRYM Stock | USD 0.02 0.0005 2.67% |
With this module, you can analyze Cryomass financials for your investing period. You should be able to track the changes in Cryomass Technologies individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Cryomass |
Understanding current and past Cryomass Technologies Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cryomass Technologies' financial statements are interrelated, with each one affecting the others. For example, an increase in Cryomass Technologies' assets may result in an increase in income on the income statement.
The data published in Cryomass Technologies' official financial statements typically reflect Cryomass Technologies' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Cryomass Technologies' quantitative information. For example, before you start analyzing numbers published by Cryomass accountants, it's essential to understand Cryomass Technologies' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Cryomass Technologies Stock Summary
Cryomass Technologies competes with CbdMD, Evolus, Akanda Corp, Biofrontera, and Collegium Pharmaceutical. Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado. Cryomass Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQX Exchange |
| Business Address | 1001 Bannock Street, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | cryomass.com |
| Phone | 303 416 7208 |
| Currency | USD - US Dollar |
Cryomass Technologies Key Financial Ratios
There are many critical financial ratios that Cryomass Technologies' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cryomass Technologies reports annually and quarterly.| Return On Equity | -1.16 | |||
| Return On Asset | -0.33 | |||
| Beta | 5.22 |
Cryomass Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cryomass Technologies's current stock value. Our valuation model uses many indicators to compare Cryomass Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cryomass Technologies competition to find correlations between indicators driving Cryomass Technologies's intrinsic value. More Info.Cryomass Technologies is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cryomass Technologies' earnings, one of the primary drivers of an investment's value.Cryomass Technologies Systematic Risk
Cryomass Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cryomass Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Cryomass Technologies correlated with the market. If Beta is less than 0 Cryomass Technologies generally moves in the opposite direction as compared to the market. If Cryomass Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cryomass Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cryomass Technologies is generally in the same direction as the market. If Beta > 1 Cryomass Technologies moves generally in the same direction as, but more than the movement of the benchmark.
Cryomass Technologies December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cryomass Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cryomass Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cryomass Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Cryomass OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cryomass Technologies's daily price indicators and compare them against related drivers.
| Downside Deviation | 11.38 | |||
| Information Ratio | 0.0223 | |||
| Maximum Drawdown | 87.29 | |||
| Value At Risk | (18.80) | |||
| Potential Upside | 31.16 |
Other Information on Investing in Cryomass OTC Stock
Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.